Alliance Global Partners Initiates Coverage On AcelRx Pharmaceuticals With Buy Rating, Announces Price Target of $4.25
Alliance Global Partners Initiates Coverage On AcelRx Pharmaceuticals With Buy Rating, Announces Price Target of $4.25
Alliance Global Partners以买入评级开始对AcelRx Pharmicals进行报道,宣布目标股价为4.25美元
Alliance Global Partners analyst James Molloy initiates coverage on AcelRx Pharmaceuticals (NASDAQ:ACRX) with a Buy rating and announces Price Target of $4.25.
Alliance Global Partners分析师詹姆斯·莫洛伊以买入评级开始对AcelRX Pharmicals(纳斯达克股票代码:ACRX)进行报道,并宣布目标股价为4.25美元。